Search research articles
Contact Us
Filters
Showing results (651-660 of 706) with videos related to
Page
of 71
Sort By:
International Journal of Cardiology
|
August 22, 2015
Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study
Francisco Fuentes, Juan F Alcala-Diaz, Gerald F Watts, et al.
European Heart Journal
|
April 29, 2016
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G Nordestgaard, Anne Langsted, Samia Mora, et al.
European Heart Journal
|
May 3, 2011
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M John Chapman, Henry N Ginsberg, Pierre Amarenco, et al.
Clinical Chemistry
|
May 29, 2016
Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G Nordestgaard, Anne Langsted, Samia Mora, et al.
Public Health Genomics
|
June 12, 2026
The IMPACT-FH Renewal Protocol: Evaluating FH Cascade Testing Implementation in Primary Care through a Pragmatic Trial, Economic Evaluation, and Mixed-Methods Sustainability Assessment
Kelly M Morgan, Nicole L Walters, Jazmine Gabriel, et al.
European Journal of Preventive Cardiology
|
December 5, 2021
A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort
Leopoldo Pérez de Isla, Gerald F Watts, Ovidio Muñiz-Grijalvo, et al.
Molecular Systems Biology
|
March 4, 2017
Personal model-assisted identification of NAD<sup>+</sup> and glutathione metabolism as intervention target in NAFLD
Adil Mardinoglu, Elias Bjornson, Cheng Zhang, et al.
Journal of Atherosclerosis and Thrombosis
|
July 8, 2016
Translational Research for Improving the Care of Familial Hypercholesterolemia: The "Ten Countries Study" and Beyond
Gerald F Watts, Phillip Ya Ding, Peter George, et al.
Journal of the American College of Cardiology
|
March 19, 2016
Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up
Leopoldo Perez de Isla, Rodrigo Alonso, Gerald F Watts, et al.
Clinical Chemistry
|
May 16, 2018
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Michel R Langlois, M John Chapman, Christa Cobbaert, et al.
Page
of 71
Search research articles
Search
Showing results (651-660 of 706) with videos related to
Sort By:
Page
of 71
International Journal of Cardiology
|
August 22, 2015
Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study
Francisco Fuentes, Juan F Alcala-Diaz, Gerald F Watts, et al.
European Heart Journal
|
April 29, 2016
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G Nordestgaard, Anne Langsted, Samia Mora, et al.
European Heart Journal
|
May 3, 2011
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M John Chapman, Henry N Ginsberg, Pierre Amarenco, et al.
Clinical Chemistry
|
May 29, 2016
Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G Nordestgaard, Anne Langsted, Samia Mora, et al.
Public Health Genomics
|
June 12, 2026
The IMPACT-FH Renewal Protocol: Evaluating FH Cascade Testing Implementation in Primary Care through a Pragmatic Trial, Economic Evaluation, and Mixed-Methods Sustainability Assessment
Kelly M Morgan, Nicole L Walters, Jazmine Gabriel, et al.
European Journal of Preventive Cardiology
|
December 5, 2021
A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort
Leopoldo Pérez de Isla, Gerald F Watts, Ovidio Muñiz-Grijalvo, et al.
Molecular Systems Biology
|
March 4, 2017
Personal model-assisted identification of NAD<sup>+</sup> and glutathione metabolism as intervention target in NAFLD
Adil Mardinoglu, Elias Bjornson, Cheng Zhang, et al.
Journal of Atherosclerosis and Thrombosis
|
July 8, 2016
Translational Research for Improving the Care of Familial Hypercholesterolemia: The "Ten Countries Study" and Beyond
Gerald F Watts, Phillip Ya Ding, Peter George, et al.
Journal of the American College of Cardiology
|
March 19, 2016
Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up
Leopoldo Perez de Isla, Rodrigo Alonso, Gerald F Watts, et al.
Clinical Chemistry
|
May 16, 2018
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Michel R Langlois, M John Chapman, Christa Cobbaert, et al.
Page
of 71